Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 13, 2026
Wells Fargo (WFC) Eyes the $100 Mark with +17% Upside Potential

Wells Fargo (WFC) Eyes the $100 Mark with +17% Upside Potential

Key Takeaways

  • The $100 price target for Wells Fargo & Company (WFC) represents a widely discussed psychological milestone and aligns with the upper range of Wall Street analyst consensus, which averages approximately $98.
  • Bullish catalysts include the lifting of the Federal Reserve's asset cap, termination of all outstanding consent orders, a loan book surpassing $1 trillion, and aggressive expansion in investment banking and wealth management.
  • Key obstacles include potential net interest income softness if deposit costs remain elevated, slowing consumer spending from macroeconomic pressures, and the possibility that much of the re-rating story is already priced in after the stock's rally.
  • Technically, the 52-week high near $98 serves as immediate resistance, while major support sits near the $80 zone where the 50-day moving average has provided a floor during recent pullbacks.
  • The path to $100 appears realistic but likely requires a successful second-half earnings inflection and continued loan growth to validate analyst optimism.

Why the $100 Level Matters

For Wells Fargo & Company (NYSE: WFC), the $100 mark carries both psychological and analytical significance. It sits just above the analyst consensus price target of roughly $98, where more than two dozen Wall Street firms have collectively placed their average 12-month forecast. Several prominent institutions — including Bank of America at $102, Morgan Stanley at $102, and UBS at $104 — have published targets above $100, framing it as a credible near-term objective rather than aspirational speculation. With shares trading around $85.50 in early July 2026, reaching $100 would require approximately 17% upside, a move well within the historical annual range for large-cap bank stocks during favorable cycles.

The End of the Asset Cap Era

The single most transformative development for Wells Fargo's investment case has been the removal of regulatory shackles that constrained the bank for years. The Federal Reserve's $1.95 trillion asset cap — imposed in 2018 following the fake accounts scandal — was lifted in 2025, restoring Wells Fargo's ability to grow its balance sheet across every business line. In March 2026, the Fed terminated its final outstanding consent order, closing a chapter that had consumed billions in remediation costs and years of management attention. With 14 consent orders resolved since 2019, the bank now operates without the regulatory overhang that kept its valuation compressed relative to peers for nearly a decade.

Current Market Position and Momentum

WFC enters the second half of 2026 with genuine momentum. The loan book crossed $1 trillion in period-end balances for the first time since early 2020, driven by 16.4% growth in commercial lending. Investment banking revenue grew 13% year-over-year in the first quarter, while markets revenue surged 19%. The wealth and investment management division reported client assets of $2.2 trillion with net asset flows at their highest level in over a decade. CEO Charlie Scharf described the deal pipeline entering 2026 as "meaningfully greater than it has been at any point in the last five years." The bank also announced an expected 11% dividend increase to $0.50 per share, subject to board approval, signaling confidence in capital generation. In my view, these developments mark a clear shift from the constrained years.

Factors That Could Drive the Next Leg Higher

Several factors could propel WFC toward $100. First, the investment banking and markets buildout remains in early innings, with the bank continuing to hire senior talent across M&A advisory and capital markets. Each incremental gain in wallet share adds high-return fee income that the franchise did not capture during the asset cap years. Second, the credit card and auto lending expansions are compounding into the origination pipeline — new credit card account growth jumped nearly 60% year-over-year in Q1, and auto originations more than doubled. Third, efficiency initiatives continue to bear fruit, with headcount falling for 23 consecutive quarters while technology and frontline hiring receive reinvestment. Finally, proposed Basel III capital rule revisions could reduce risk-weighted assets by approximately 7%, freeing excess capital for buybacks or further balance sheet deployment. One thing that stands out here is how these drivers appear to be compounding rather than isolated.

Analyst Opinions and Price Targets

Wall Street remains broadly constructive on Wells Fargo. Of 25 analysts covering the stock, the consensus rating stands at "Buy" with an average price target of $97.75, according to S&P Global data. The high target of $113 comes from Barclays, while even the lowest target sits at $85 — roughly in line with current trading levels. Bank of America raised its target to $102 in July 2026, citing idiosyncratic earnings drivers and a return on tangible common equity projected to reach 17% by 2028. TD Cowen and Keefe, Bruyette & Woods maintain targets at or near $100, while HSBC upgraded the stock to Buy with a $94 objective. The clustering of targets around the $100 mark underscores how broadly that level features in institutional thinking. From what I see, this level of alignment is noteworthy.

What Could Prevent the Move

Net interest income remains the primary wildcard. The first quarter of 2026 saw NII come in at $12.1 billion against estimates of $12.3 billion, and if deposit mix continues tilting toward higher-cost interest-bearing accounts — a dynamic that persists in an elevated rate environment — the income trajectory could disappoint. Consumer-exposed segments drive over 40% of Wells Fargo's revenue, making the stock sensitive to any softening in household spending. Private credit exposure of $36.2 billion, while well-structured, could attract incremental regulatory attention. Additionally, the stock's rally from its 52-week low of $72.78 has already priced in significant optimism, leaving less room for error if execution stumbles.

Technical Levels That Matter

From a technical perspective, the $85 area has become a battleground, with the stock consolidating near the midpoint of its 52-week range. The 52-week high of $97.76 represents the clearest resistance — a breakout above that level would place $100 within direct reach. The 50-day simple moving average near $80 and the 200-day moving average around $84 provide structural support, while the 52-week low at $72.78 marks the downside extreme. Breaking through $100 would likely require a catalyst-driven move rather than gradual appreciation, making the upcoming July 14 earnings report a particularly important event for the stock's near-term trajectory. I’m watching this closely as the setup develops.

Valuation Perspective

Wells Fargo trades at approximately 13.2 times trailing earnings and roughly 11.8 times forward estimates, a discount to JPMorgan Chase's (JPM) 14.2 times forward multiple. The price-to-book ratio sits around 1.5, above the distressed levels seen during the asset cap era but still below what a fully unconstrained franchise could command. If the bank delivers the 16% average annual EPS growth that Bank of America projects through 2028, the current valuation provides room for price appreciation toward and potentially beyond $100 without requiring multiple expansion. The stock's 2.06% dividend yield adds a tangible return component while investors wait for capital appreciation catalysts to materialize.

Monitoring with AI Daily Buy/Sell Signals

Monitoring price action around major thresholds requires consistent attention, and I have found AI Daily Buy/Sell Signals from Tickeron to be a useful addition to the process. This tool uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI-driven analysis. For a stock like Wells Fargo approaching a well-defined target zone, automated signal generation can help identify shifts in momentum without manually tracking every data point. Traders use these signals to spot emerging opportunities, monitor existing positions, and stay informed about changing market trends with greater efficiency. In my experience, incorporating this type of analysis alongside traditional research provides additional context when evaluating setups like the current one for WFC.

Final Assessment

The $100 target for Wells Fargo appears realistic but not automatic. The bank possesses genuine idiosyncratic growth drivers — a cleared regulatory record, an accelerating investment banking franchise, expanding consumer lending platforms, and a disciplined efficiency program — that differentiate it from peers trading at higher multiples. The analyst community has broadly endorsed the path toward $100, with multiple firms publishing targets at or above that level. However, the move depends on net interest income stabilizing and loan growth compounding through the second half of 2026. The upcoming earnings report on July 14 will provide a critical data point. Investors should monitor NII trends, deposit mix evolution, and consumer credit performance, as these factors will determine whether $100 becomes a near-term destination or a longer-term objective.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: WFC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


WFC in upward trend: price may jump up because it broke its lower Bollinger Band on July 29, 2026

WFC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 39 cases where WFC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on WFC as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for WFC just turned positive on August 05, 2026. Looking at past instances where WFC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for WFC moved above the 200-day moving average on August 06, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WFC advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 253 cases where WFC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WFC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock worse than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. WFC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.607) is normal, around the industry mean (1.949). P/E Ratio (12.731) is within average values for comparable stocks, (16.293). Projected Growth (PEG Ratio) (1.656) is also within normal values, averaging (1.624). Dividend Yield (0.021) settles around the average of (0.025) among similar stocks. P/S Ratio (3.163) is also within normal values, averaging (4.347).

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Bank of America Corp (NYSE:BAC), HSBC Holdings PLC (NYSE:HSBC), Wells Fargo & Co (NYSE:WFC), Citigroup (NYSE:C), Barclays PLC (NYSE:BCS).

Industry description

Major banks are among the biggest companies in the world, often times with global reach and market capitalizations in the multi-billions. Large banks often have multiple arms spanning different disciplines, from deposits, to investment banking, to wealth management and insurance. The biggest banks often have key competitive advantages over smaller players in the industry in terms of brand recognition, cost of capital, and efficiency. Think J.P. Morgan, Bank of America, Wells Fargo, and Citigroup.

Market Cap

The average market capitalization across the Major Banks Industry is 216.73B. The market cap for tickers in the group ranges from 1.04M to 947.12B. JPM holds the highest valuation in this group at 947.12B. The lowest valued company is BACRP at 1.04M.

High and low price notable news

The average weekly price growth across all stocks in the Major Banks Industry was 1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 17%. SAN experienced the highest price growth at 4%, while HSBC experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Major Banks Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was -9% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 29
Price Growth Rating: 39
SMR Rating: 8
Profit Risk Rating: 19
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
WFC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a major bank

Industry MajorBanks

Profile
Details
Industry
Major Banks
Address
420 Montgomery Street
Phone
+1 866 249-3302
Employees
226000
Web
https://www.wellsfargo.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.